Juniper Pharmaceuticals Inc (Nasdaq: JNP), a diversified healthcare company with core businesses the CRINONE (progesterone gel) franchise and fee-for-service pharmaceutical development and manufacturing business JPS, has named Richard Messina as its new director, it was reported yesterday.

The new director is the founder, president and chief executive officer of The Benchmark Company LLC, an investment banking and financial advisory firm.

Alicia Secor, Juniper's president and CEO, said, 'We welcome Richard to Juniper's Board of Directors. As a long-term shareholder, Richard's perspective will be a valuable contribution to our ongoing process of reviewing strategic alternatives while we continue to drive growth in our core businesses. Richard has witnessed Juniper transform throughout the years, and we look forward to working with him as we seek to build shareholder value.'